These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20888268)

  • 1. Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience.
    Coppola G; Grosso S; Franzoni E; Veggiotti P; Zamponi N; Parisi P; Spalice A; Habetswallner F; Fels A; Capovilla G; Verrotti A; Mangano S; Balestri A; Curatolo P; Pascotto A
    Seizure; 2010 Nov; 19(9):587-91. PubMed ID: 20888268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and tolerability of rufinamide in children and young adults with Lennox-Gastaut syndrome: a single center study in Korea.
    Lee EH; Yum MS; Ko TS
    Clin Neurol Neurosurg; 2013 Jul; 115(7):926-9. PubMed ID: 23083943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: the first Italian prospective study.
    Moavero R; Cusmai R; Specchio N; Fusco L; Capuano A; Curatolo P; Vigevano F
    Epilepsy Res; 2012 Nov; 102(1-2):94-9. PubMed ID: 22677424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rufinamide as an adjuvant treatment in children with Lennox-Gastaut syndrome.
    Kim SH; Eun SH; Kang HC; Kwon EJ; Byeon JH; Lee YM; Lee JS; Eun BL; Kim HD
    Seizure; 2012 May; 21(4):288-91. PubMed ID: 22421185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy.
    Kim SH; Lee JH; Ryu HW; Lim BC; Chae JH; Choi JE; Hwang YS; Kim KJ
    Epileptic Disord; 2013 Mar; 15(1):49-54. PubMed ID: 23531645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan.
    Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
    Epilepsy Res; 2014 Nov; 108(9):1627-36. PubMed ID: 25219353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial.
    Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
    Epilepsy Res; 2016 Mar; 121():1-7. PubMed ID: 26827266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rufinamide for refractory focal seizures: an open-label, multicenter European study.
    Coppola G; Zamponi N; Kluger G; Mueller A; Anna Rita M; Parisi P; Isone C; Santoro E; Curatolo P; Verrotti A
    Seizure; 2013 Jan; 22(1):33-6. PubMed ID: 23079159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome.
    Coppola G; Grosso S; Franzoni E; Veggiotti P; Zamponi N; Parisi P; Spalice A; Habetswallner F; Fels A; Verrotti A; D'Aniello A; Mangano S; Balestri A; Curatolo P; Pascotto A
    Eur J Neurol; 2011 Feb; 18(2):246-251. PubMed ID: 20666837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience.
    Thome-Souza S; Kadish NE; Ramgopal S; Sánchez Fernández I; Bergin AM; Bolton J; Harini C; Libenson M; Olson H; Peters J; Poduri A; Rotenberg A; Takeoka M; Kothare SV; Kapur K; Bourgeois BF; Loddenkemper T
    Epilepsia; 2014 Aug; 55(8):1235-44. PubMed ID: 25070475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rufinamide as add-on therapy in children with epileptic encephalopathies other than Lennox-Gastaut syndrome: A study of 34 patients.
    Caraballo RH; Pociecha J; Reyes G; Espeche A; Galichio S; Fasulo L; Semprino M
    Epilepsy Behav; 2020 Jul; 108():107074. PubMed ID: 32334364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rufinamide in children under four years of age with drug-resistant epilepsies.
    Grosso S; Coppola G; Dontin SD; Gobbi G; Pruna D; Accorsi P; Verrotti A; Parisi P; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):641-5. PubMed ID: 24912730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
    McCormack PL
    Pharmacoeconomics; 2012 Mar; 30(3):247-56. PubMed ID: 22332960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication.
    May TW; Boor R; Rambeck B; Jürgens U; Korn-Merker E; Brandt C
    Ther Drug Monit; 2011 Apr; 33(2):214-21. PubMed ID: 21383651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders.
    Cusmai R; Verrotti A; Moavero R; Curatolo P; Battaglia D; Matricardi S; Spalice A; Vigevano F; Pruna D; Parisi P; D'Aniello A; Di Gennaro G; Coppola G
    Epilepsy Res; 2014 Mar; 108(3):542-6. PubMed ID: 24548548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview.
    Wier HA; Cerna A; So TY
    Paediatr Drugs; 2011 Apr; 13(2):97-106. PubMed ID: 21351809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
    Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
    Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.